Quick Dispatch:
Your first large study of glp-1 receptor agonists during pregnancy Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your first large study of glp-1 receptor agonists during pregnancy Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review ships.
Need Help?
Questions about first large study of glp-1 receptor agonists during pregnancy Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for first large study of glp-1 receptor agonists during pregnancy Impact of semaglutide exposure on fetal and neonatal outcomes in pregnant women: a systematic review in your area.
Frontiers
28.98
Navigating GLP-1 and Pregnancy: Insights, Safety, and Postpartum Considerations
26.45
GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja.ma/3XPqgQT
20.64
Frontiers
25.45
Frontiers
20.58
💬 Editorial: #GLP-1 receptor agonists have transformed obesity management, but reproductive safety remains uncertain. Maya et al report greater gestational weight gain and increased risk of preterm delivery, gestational diabetes, and hypertension
23.05
Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)
29.20
